Diabetes Online-Kongress 2021
Kalender Liste Personen Favoriten
zur Liste
Dr. Joachim Kienhöfer
Novo Nordisk Pharma GmbH Germany
  • Vortrag Efficacy of Semaglutide by Background Sodium–Glucose Co-Transporter-2 Inhibitor: a Post Hoc Analysis of SUSTAIN 9 Speaker
    Datum: 14.05.2021 , Zeit: 09:26 | Thema: Posterkurzvortrag
    Details

zur online Kongressplattform